Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performanceElisabeth Ploran, Chris Tang, Meggan Mackay, Michael Small, Erik Anderson, Justin Storbeck, Brittany Bascetta, Simran Kang, Cynthia Aranow, Carl Sartori, Philip Watson, Bruce Volpe, Betty Diamond, David Eidelberg
11 July 2019
Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survivalBasile Tessier-Cloutier, David DW Twa, Eva Baecklund, Randy Gascoyne, Nathalie A Johnson, Carin Backlin, Diane L Kamen, Ann E Clarke, Rosalind Ramsey-Goldman, Jennifer LF Lee, Pedro Farinha, Sasha Bernatsky
4 May 2019
Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factorsSahena Haque, Sarah Skeoch, Chadi Rakieh, Helena Edlin, Yasmeen Ahmad, Pauline Ho, Rachel Gorodkin, M Yvonne Alexander, Ian N Bruce
17 November 2018
Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centresChiara Tani, Elena Elefante, Miguel Martin-Cascón, Meriem Belhocine, Cristina Lavilla Olleros, Roberta Vagelli, Chiara Stagnaro, Nathalie Costedoat-Chalumeau, Guillermo Ruiz-Irastorza, Marta Mosca
2 November 2018
Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus CohortIoanna Giannakou, Katerina Chatzidionysiou, Laurence S Magder, Noemi Györi, Ronald van Vollenhoven, Michelle A Petri
2 November 2018
Immunosuppressant use and hospitalisations in adult patients with systemic lupus erythematosus admitted to a tertiary academic medical centreChristine Anastasiou, Olivia Dulai, Amrutha Baskaran, James Proudfoot, Samuel Verhaegen, Kenneth Kalunian
4 June 2018
Quantifying the burden of steroid-related damage in SLE in the Hopkins Lupus CohortJulie E Davidson, Qinggong Fu, Sapna Rao, Laurence S Magder, Michelle Petri
14 May 2018
Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohortChiara Tani, Roberta Vagelli, Chiara Stagnaro, Linda Carli, Marta Mosca
27 February 2018
Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosusJoseph M Kheir, Carla J Guthridge, Jonathon R Johnston, Lucas J Adams, Astrid Rasmussen, Timothy F Gross, Melissa E Munroe, Rebecka L Bourn, Kathy L Sivils, Joel M Guthridge, Michael H Weisman, Daniel J Wallace, Juan-Manuel Anaya, Adriana Rojas Villarraga, James N JarvisSee the full list of authors
27 February 2018
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational surveyPintip Ngamjanyaporn, Eoghan M McCarthy, Jamie C Sergeant, John Reynolds, Sarah Skeoch, Benjamin Parker, Ian N Bruce
29 June 2017